DERM — Journey Medical Corp
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1867066 ·
Last close
$3.90
Market Cap
$86.70M
52W High
$9.56
52W Low
$3.40
ADV30
218,520
Next earnings
2026-11-12
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | 18,967,000 | 13,083,000 | -530,000 | -1,315,000 | 103,846,000 | 22,323,000 | 71,597,000 |
| Jun 2026 | 18,510,000 | 12,367,000 | 456,000 | -312,000 | 98,356,000 | 25,643,000 | 66,242,000 |
| Mar 2026 | 15,961,000 | 9,743,000 | -1,492,000 | -2,230,000 | 91,534,000 | 27,219,000 | 60,703,000 |
| Dec 2025 | 16,079,000 | 10,639,000 | -443,000 | -1,247,000 | 94,589,000 | 24,090,000 | 62,737,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-7,492,000
Investing CF
—
Financing CF
$12,842,000
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.34
As of
2026-11-15
Balance + Analyst (yfinance extras)
Retained Earnings
$-101,000,000
Inventory
$8,156,000
Receivables
$36,246,000
ST Investments
—
EBIT TTM
$-2,421,000
Pretax Income TTM
$-6,089,000
Interest Exp TTM
$3,668,000
Analysts
3
Yahoo Snapshot (yfinance, live)
Total Revenue
$69,517,000
EBITDA
$2,120,000
Free Cash Flow
$-6,126,875
Enterprise Value
$125,536,696
Total Cash
$22,323,000
Total Debt
$25,621,000
Shares Out
22,230,645
Trailing EPS
$-0.18
Book Value
$1.14
ROE
-17.6%
ROA
-1.3%
Div Yield
0.00%
Annual Trend (SEC EDGAR, last 5y)
Revenues vs Net Income (last 5y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 61,858,000 | -8,172,000 | -11,431,000 | 94,589,000 | 62,737,000 | 31,852,000 | -12,441,000 |
| Dec 2024 | 56,134,000 | -18,230,000 | -14,672,000 | 80,241,000 | 60,172,000 | 20,069,000 | -9,127,000 |
| Dec 2023 | 79,181,000 | 1,070,000 | -3,853,000 | 76,849,000 | 56,499,000 | 20,350,000 | 5,240,000 |
| Dec 2022 | 73,669,000 | -27,517,000 | -29,628,000 | 105,160,000 | 88,178,000 | 16,982,000 | -13,534,000 |
| Dec 2021 | — | — | — | — | — | — | — |
TTM Snapshot
Revenues TTM
$68,181,000
NetIncome TTM
$-6,104,000
OpCashFlow TTM
—
Assets (Latest)
$98,356,000
Forward EPS
$-0.06
Max Pain — expiry 2027-02-19 (volume-derived — Yahoo OI feed degraded)
max pain strike: $5.00 · spot: $3.69 · call volume: 4 · put volume: 6Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| RVRC | Revium Rx. | $86.84M | $1.43 | — |
| CPIX | CUMBERLAND PHARMACEUTICALS INC | $86.96M | $5.80 | — |
| HURA | TuHURA Biosciences, Inc./NV | $89.22M | $1.40 | — |
| NKTX | Nkarta, Inc. | $89.53M | $1.25 | — |
| ZOMDF | Zomedica Corp. | $83.30M | $0.09 | — |
News headlines (Yahoo Finance, 1h cache)
Fortress Biotech (FBIO) Q3 2026 Earnings Call Transcript
2026-11-13 13:58 · Yahoo
Journey Medical Corporation Q3 2026 Earnings Call Summary
2026-11-13 13:30 · Yahoo
Journey Medical (DERM) Q3 2026 Earnings Call Transcript
2026-11-13 06:15 · Yahoo
Journey Medical Corp (DERM) Q3 2026 Earnings Call Highlights: Emrosi Momentum Drives Revenue ...
2026-11-13 05:03 · Yahoo
Fortress Biotech Q3 Earnings Call Highlights
2026-11-13 01:14 · Yahoo
What Journey Medical (DERM) Said on Its Q3 Earnings Call
2026-11-12 23:14 · Yahoo
Journey Medical (DERM) Reports Q3 Earnings: What Key Metrics Have to Say
2026-11-12 22:30 · Yahoo
Journey Medical Corporation (DERM) Reports Q3 Loss, Lags Revenue Estimates
2026-11-12 21:25 · Yahoo
Journey Medical Corporation Reports Third Quarter 2026 Financial Results and Recent Corporate Highlights
2026-11-12 21:01 · Yahoo
Journey Medical Corporation to Announce Third Quarter 2026 Financial Results on November 12, 2026
2026-11-05 13:30 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.